Zietek Z, Iwan-Zietek I, Kotschy M, Tyloch F
Katedry i Zakładu Patofizjologii, Katedry i Kliniki Urologii Akademii Medycznej, Bydgoszczy.
Pol Tyg Lek. 1996 Feb;51(6-9):89-90.
The activity of alpha 1-antitrypsin in patients with prostatic carcinoma and benign prostatic hyperplasia was examined. The activity of alpha 1-antitrypsin was higher in patients with prostatic carcinoma. The higher activity of alpha 1-antitrypsin is good prognostic sign for patients with prostatic carcinoma because it is born of large defense possibilities in these patients against the disease.
对前列腺癌患者和良性前列腺增生患者的α1-抗胰蛋白酶活性进行了检测。前列腺癌患者的α1-抗胰蛋白酶活性较高。α1-抗胰蛋白酶活性较高对前列腺癌患者来说是一个良好的预后标志，因为这源于这些患者对疾病有较大的防御能力。
